FORM DEF 14A

Company

Moleculin Biotech, Inc.

Filed

March 9, 2026

Period of Report

April 15, 2026

Accession Number

0001437749-26-007331

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →